Gradient coating for biomedical applications
US-9011965-B2 · Apr 21, 2015 · US
US12022822B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12022822-B2 |
| Application number | US-202117179795-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 19, 2021 |
| Priority date | Jul 9, 2010 |
| Publication date | Jul 2, 2024 |
| Grant date | Jul 2, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A medical product including an antibacterial hard material coating, which is applied to a main body and which includes biocide. The hard material coating includes at least one inner layer and one outer layer, wherein the biocide concentration in the outer layer is substantially constant and greater than the biocide concentration in the inner layer and the biocide concentration in the inner layer is greater than or equal to 0.2 at %.
Opening claim text (preview).
The invention claimed is: 1. A medical product with an antibacterial hard material coating comprising a biocide applied to a main body, the hard material coating consisting of a bonding layer, an inner layer, and an outer layer, wherein the inner layer is between the outer layer and the main body, the bonding layer is between the inner layer and the main body, the bonding layer contains essentially no biocide, the outer layer has a biocide concentration (bcI) of 2 at % to 15 at %, the inner layer has a biocide concentration (bcII) that is greater than or equal to 0.2 at % and less than bcI, and the biocide concentration (bcII) of the inner layer increases in a direction from the main body toward the outer layer. 2. The medical product of claim 1 , wherein the inner layer has a thickness (d 1 ) of at least 0.2 μm. 3. The medical product of claim 1 , wherein the outer layer has a thickness (d 2 ) of at least 0.5 μm. 4. The medical product of claim 1 , wherein bcI is substantially constant throughout the outer layer. 5. The medical product of claim 1 , the hard material coating comprising one or more of TiN, TiAlN, AlTiN, CrN, WC/C or a-C:H. 6. The medical product of claim 1 , wherein the biocide is a non-organic biocide. 7. The medical product of claim 6 , wherein the non-organic biocide is silver. 8. The medical product of claim 1 , wherein the outer layer has a hardness of 17 to 32 GPa. 9. The medical product of claim 1 , wherein the inner layer is diamond-like carbon (DLC).
Heavy metals; Compounds thereof · CPC title
having two or more layers · CPC title
Biocides, antimicrobial agents, antiseptic agents · CPC title
Silver, e.g. silver sulfadiazine · CPC title
Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.